Safety and Efficacy of 6-Tioguanine in Mice with Colitis
Author Information
Author(s): Kverka Miloslav, Rossmann Pavel, Tlaskalova-Hogenova Helena, Klimesova Klara, Jharap Bindia, de Boer Nanne K, Vos Rene M, van Bodegraven Adriaan A, Lukas Milan, Mulder Chris J
Primary Institution: Department of Immunology and Gnotobiology, Institute of Microbiology, Academy of Sciences of the Czech Republic
Hypothesis
Is 6-tioguanine more effective and less toxic than azathioprine in treating colitis in mice?
Conclusion
6-TG is more effective and less toxic than AZA in treating acute colitis in mice.
Supporting Evidence
- 40 μg of 6-TG is significantly more effective in treating acute colitis than both AZA and PBS.
- High doses of 6-TG led to significant weight loss, but did not increase serum ALT levels.
- 6-TG reduced the proportion of apoptotic T helper cells.
- AZA treatment resulted in histological liver abnormalities, while 6-TG did not.
Takeaway
This study shows that a medicine called 6-tioguanine works better and is safer than another medicine called azathioprine for treating sick mice with gut problems.
Methodology
Mice were treated with different dosages of 6-tioguanine or azathioprine after inducing colitis with dextran sulfate sodium, and various health indicators were measured.
Potential Biases
Potential bias in treatment effects due to the animal model used.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Conventional female, 3-month-old BALB/c mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website